4
Participants
Start Date
June 30, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
April 30, 2014
Thalidomide
Thalidomide 50 mg (every ODD day of a 28 day cycle: Days 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25 \& 27)
Lenalidomide
Lenalidomide (every EVEN day of a 28 day cycle: Days 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 \& 28). Lenalidomide will be initiated at a starting dose of 5 mg.
Rituximab
Rituximab 375 mg/m2 IV on Days 1, 8, 15 and 22 (+/- 2 days) and then again on the same weekly x 4 schedule every 6th cycle thereafter (Cycle 7, 13, 19, etc).
Weill Cornell Medical College, New York
Collaborators (1)
Celgene Corporation
INDUSTRY
Weill Medical College of Cornell University
OTHER